https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-08-15 / Oncotarget 2014 Aug;5(15):6365-74
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-08-15 / Oncotarget 2014 Aug;5(15):6365-742014-08-15 00:00:002019-02-15 09:21:22Mitophagy promotes replication of oncolytic Newcastle disease virus by blocking intrinsic apoptosis in lung cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-08-12 / Front Oncol 2014;4:217
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-08-12 / Front Oncol 2014;4:2172014-08-12 00:00:002019-02-15 09:22:37Attacking Postoperative Metastases using Perioperative Oncolytic Viruses and Viral Vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-07-30 / BMC Cancer 2014 Jul;14:551
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-07-30 / BMC Cancer 2014 Jul;14:5512014-07-30 00:00:002014-07-30 00:00:00Pharmacological modulation of autophagy enhances Newcastle disease virus-mediated oncolysis in drug-resistant lung cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-07-05 / Virology 2014 Aug;462-463:283-94
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-07-05 / Virology 2014 Aug;462-463:283-942014-07-05 00:00:002019-02-15 09:21:23ISG12a mediates cell response to Newcastle disease viral infection
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-07-03 / Nat. Rev. Cancer 2014 Aug;14(8):559-67
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-07-03 / Nat. Rev. Cancer 2014 Aug;14(8):559-672014-07-03 00:00:002019-02-15 09:22:39Going viral with cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-06-18 / J. Immunol. 2014 Jul;193(2):735-45
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-06-18 / J. Immunol. 2014 Jul;193(2):735-452014-06-18 00:00:002019-02-15 09:21:24Autologous tumor vaccine modified with recombinant new castle disease virus expressing IL-7 promotes antitumor immune response
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-06-11 / Front Oncol 2014;4:145
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-06-11 / Front Oncol 2014;4:1452014-06-11 00:00:002019-02-15 09:22:41Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3062)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3062)2014-06-01 00:00:002014-06-01 00:00:00γδ T cells in combination with Newcastle disease virus and dendritic cell therapy as a novel immunotherapeutic approach in treating of advanced lung cancer.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3051)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3051)2014-06-01 00:00:002014-06-01 00:00:00Potentiation of immune checkpoint blockade cancer immunotherapy with oncolytic virus.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-05-12 / Virol. J. 2014 May;11:84
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-05-12 / Virol. J. 2014 May;11:842014-05-12 00:00:002014-05-12 00:00:00Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer
